Miller-Urey Amino Acids, circa 1953

Credit: Courtesy of Adam Johnson" /> Credit: Courtesy of Adam Johnson When chemistry graduate student Stanley Miller first heard University of Chicago professor and Nobel laureate Harold Urey's idea that organic compounds, such as amino acids, arose in a reducing atmosphere, Miller was determined to find out. Together, they built the spark-charge apparatus—two glass flasks connected by glass t

Written byJennifer Evans
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

When chemistry graduate student Stanley Miller first heard University of Chicago professor and Nobel laureate Harold Urey's idea that organic compounds, such as amino acids, arose in a reducing atmosphere, Miller was determined to find out. Together, they built the spark-charge apparatus—two glass flasks connected by glass tubing. Miller filled one flask with water to represent the ocean; to the other, he sucked out oxygen and pumped in methane, ammonium, and hydrogen—the chemicals then believed to comprise the early atmosphere. Miller used electrodes to generate a spark in the "atmosphere" flask, simulating early lightning. After one week, Miller detected the presence of five different amino acids, offering the first evidence that amino acids could be produced in the atmosphere of primitive Earth.

The findings "showed for the first time that Darwin's so-called 'warm little pond' was feasible on the early Earth," says Miller's former graduate student, Jeffrey Bada, now a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies